Have more confidence in your stability data: two points to consider.
Simple statistical, mathematical, and chemical arguments are presented that will justify performing all stability studies using a different approach than is currently practiced in the pharmaceutical and IVD industries. The use of multi time point stability studies is in most cases a waste of resources that could be better spent on endpoint studies at less cost and a significant increase in the quality of the data.